Summary
Low Dose Allergen Immunotherapy (LDA) is an alternative treatment for allergies that uses extremely diluted allergens combined with a specific enzyme to train the immune system to tolerate triggers. It reportedly has a 91% success rate and applies to a wide range of conditions beyond typical allergies. Dr. Berg presents it as an option for people who haven’t found relief through foundational approaches like diet changes.
Key Takeaways
- Low Dose Allergen Immunotherapy (LDA) has a reported 91% success rate across a broad range of conditions
- LDA uses allergens diluted to extreme concentrations — as low as one part per one quadrillion — making it conceptually similar to homeopathy
- The treatment is administered via subcutaneous injection (under the skin, not into a bloodstream)
- The critical component is the enzyme beta-glucuronidase, which signals the immune system to tolerate rather than react to allergens
- LDA works with the immune system, not by suppressing it, resulting in reportedly low side effects
- Before pursuing LDA, Dr. Berg recommends addressing allergies first through electrolytes (likely “electrolytes” was meant as “allergy taquito” appears to be a transcription error — he references a foundational dietary approach) and intermittent fasting
- LDA addresses a surprisingly wide range of conditions, including autoimmune symptoms, neurological conditions, and skin disorders
Details
What Is LDA?
Low Dose Allergen Immunotherapy (LDA) is an alternative allergy treatment that exposes the immune system to an extremely broad mixture of allergens at ultra-low concentrations. Unlike conventional allergy immunotherapy, which uses progressively increasing doses of specific allergens, LDA works at dilutions as extreme as:
- 1 part per 10 million
- 1 part per 1 quadrillion
These concentrations are far below standard allergy shot protocols and are closer in principle to homeopathy.
The Role of Beta-Glucuronidase
The distinguishing feature of LDA is the addition of the enzyme beta-glucuronidase to the allergen mixture. This enzyme is described as the mechanism by which the immune system is instructed to ignore or tolerate the allergens rather than mount an inflammatory response. This is a key distinction from treatments that simply suppress immune activity — LDA is designed to retrain immune behavior naturally.
Conditions LDA May Help
LDA is noted as applicable to a wide spectrum of conditions:
- Respiratory/Environmental: hay fever, dust mite allergies, sinusitis, asthma
- Skin: hives, psoriasis, eczema
- Sensitivities: chemical sensitivities
- Autoimmune-related symptoms
- Neurological/Behavioral: ADHD, autism spectrum
- Digestive: IBS (irritable bowel syndrome)
- Pain/Neurological: migraine headaches
First-Line Recommendations
Before pursuing LDA, foundational interventions are suggested that may resolve allergies on their own:
- Dietary approach (specific protocol referenced but unclear from transcript)
- Intermittent fasting — highlighted as a potentially powerful tool for reducing allergic responses
Safety Profile
LDA is noted to have very low side effects, attributed to both the ultra-low dosing and the natural, enzyme-based mechanism that avoids immune suppression.